Form 4: Medpace Holdings Director McCarthy Exercises Stock Options
SEC Form 4 Filing
Director Cornelius P. McCarthy III of Medpace Holdings, Inc. reports the exercise of stock options and vesting of restricted stock units on December 31, 2024.
Summary
- On December 31, 2024, Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., executed transactions involving the company's stock.
- McCarthy exercised stock options, acquiring 62 shares of common stock.
- Additionally, 62 restricted stock units vested on the same date.
- Following these transactions, McCarthy directly owns 5,287 shares of Medpace Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and provides insight into the compensation structure for Medpace Holdings' directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| November 30, 2023 | Reporting Person was granted 249 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2024. |
| December 31, 2024 | Earliest transaction date; stock options exercised and restricted stock units vested. |
| January 03, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.